CXBS (Corix Bioscience) Scaled Net Operating Assets: 0.31 (As of Sep. 2017)


What is Corix Bioscience Scaled Net Operating Assets?

Corix Bioscience CXBS -99.00% Scaled Net Operating Assets is 0.31 as of Sep. 2017.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Corix Bioscience's operating assets for the quarter that ended in Sep. 2017 was $3.98 Mil. Corix Bioscience's operating liabilities for the quarter that ended in Sep. 2017 was $0.74 Mil. Corix Bioscience's Total Assets for the quarter that ended in Jun. 2017 was $10.46 Mil. Therefore, Corix Bioscience's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2017 was 0.31.

Corix Bioscience Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Corix Bioscience's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corix Bioscience Scaled Net Operating Assets Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.06 0.89 0.00 0.00 0.31

CXBS vs BKIT, YBAO, HSTI: Scaled Net Operating Assets Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Corix Bioscience Scaled Net Operating Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's Scaled Net Operating Assets falls into.


Corix Bioscience Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Corix Bioscience's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2016 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2016 )
=(Operating Assets (A: Dec. 2016 )-Operating Liabilities (A: Dec. 2016 ))/Total Assets (A: Jan. 2015 )
=(11.368-0.613)/0
=N/A

where

Operating Assets(A: Dec. 2016 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=11.37 - 0.002
=11.368

Operating Liabilities(A: Dec. 2016 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=5.764 - 5.077 - 0.074
=0.613

Corix Bioscience's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2017 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2017 )
=(Operating Assets (Q: Sep. 2017 )-Operating Liabilities (Q: Sep. 2017 ))/Total Assets (Q: Jun. 2017 )
=(3.983-0.736)/10.457
=0.31

where

Operating Assets(Q: Sep. 2017 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4.344 - 0.361
=3.983

Operating Liabilities(Q: Sep. 2017 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.786 - 0 - 0.05
=0.736

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.31 mean?
Corix Bioscience (CXBS) has a Scaled Net Operating Assets of 0.31 as of Sep. 2017. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Corix Bioscience and its competitors.
Is Corix Bioscience's Scaled Net Operating Assets too high?
Corix Bioscience's current Scaled Net Operating Assets is 0.31.
How does Corix Bioscience's Scaled Net Operating Assets compare to BKIT and YBAO?
Corix Bioscience's Scaled Net Operating Assets of 0.31 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Drug Manufacturers company?
A good Scaled Net Operating Assets depends on the Drug Manufacturers industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Corix Bioscience and its competitors. Corix Bioscience's current Scaled Net Operating Assets is 0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corix Bioscience stock overvalued right now?
Corix Bioscience (CXBS) has a current Scaled Net Operating Assets of 0.31. The current Scaled Net Operating Assets is 0.31. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Corix Bioscience (CXBS), the current Scaled Net Operating Assets is 0.31 as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Corix Bioscience Business Description

Address 18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.